AJP - Regu Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Regul Integr Comp Physiol 292: R902-R903, 2007. First published October 12, 2006; doi:10.1152/ajpregu.00716.2006
0363-6119/07 $8.00
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/R902    most recent
00716.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stauss, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stauss, H. M.

EDITORIAL FOCUS

NEUROHUMORAL CONTROL OF CARDIOVASCULAR FUNCTION

Power spectral analysis in mice: what are the appropriate frequency bands?

Harald M. Stauss

Department of Integrative Physiology, The University of Iowa, Iowa City, Iowa

Submitted 9 October 2006 ; accepted in final form 11 October 2006

PROPER FUNCTION OF A VARIETY of organ systems, such as the kidneys, the heart, and the brain, depends on appropriate perfusion pressure. For example, a reduction in cerebral perfusion pressure below the threshold of autoregulation of cerebral blood flow can cause fainting or transient ischemic attacks (18), whereas an increase in cerebral perfusion pressure above the autoregulatory range can cause hyperperfusion, cerebral edema, or even hemorrhagic stroke (4, 5). To maintain an appropriate perfusion pressure, the body is equipped with several cardiovascular control systems aimed at maintaining blood pressure at a relatively constant level (16). These cardiovascular control systems include the baroreceptor reflex (11), the renin-angiotensin-aldosterone system (7), endothelial control of vascular tone (23), myogenic vascular function (14), and others (16). To study these cardiovascular control systems, analytical techniques have been developed that are based on the analysis of specific patterns of variability introduced to arterial blood pressure and heart rate by these cardiovascular control systems (1, 3, 13, 17, 19, 20). The underlying theory is that the time course of cardiovascular responses to activation or inhibition of individual cardiovascular control systems differs. For example, it has been demonstrated that blood pressure control by the renin-angiotensin system (17) is slower than blood pressure control by the sympathetic nervous system (21). Thus, the renin-angiotensin system affects cardiovascular variability at lower frequencies than the sympathetic nervous system (1). The frequency components of blood pressure and heart rate variability that are affected by different cardiovascular control systems have been well characterized in a variety of species, including humans, dogs, rabbits, cats, and rats (16). However, little is known about the specific frequency components of blood pressure and heart rate variability that are affected by individual cardiovascular control systems in mice. This knowledge is of particular importance, as genetically engineered mouse models are becoming more frequently used to study cardiovascular diseases.

In this issue of The American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, Baudrie, Laude, and Elghozi (2) publish a study aimed at identifying the frequency components of blood pressure and heart rate variability that are affected by sympathetic and parasympathetic nervous system activity in conscious, unrestrained mice (2). Few studies have addressed this issue before. For example, Just et al. (9) performed power spectral analysis of arterial blood pressure and pulse interval in conscious unrestrained mice during application of autonomic receptor blockers and found that {alpha}1-adrenergic receptor blockade by prazosin reduced blood pressure variability most prominently at 0.15–0.7 Hz, indicating that this frequency band reflects sympathetic modulation of vascular tone in mice. The results concerning parasympathetic modulation of heart rate were less clear, since muscarinic receptor blockade by atropine reduced heart rate variability at all frequencies with greater effects at frequencies below 1.0 Hz (9). The study by Baudrie et al. (2) differs from that of Just et al. (9) in that these authors used a statistical approach to investigate the effects of autonomic receptor blockers on a total number of 32,896 frequency bands. This huge number of frequency bands results from the permutations of lower and upper frequency limits that can be obtained based on a frequency resolution of 0.0195 Hz and a highest frequency of the power spectra of 5.0 Hz. For each of these 32,896 frequency bands a P value was calculated for the paired t-test comparing spectral powers during control conditions and autonomic receptor blockade. Based on these P values, the frequency bands of blood pressure and pulse interval variability for which autonomic receptor blockade yielded the "most significant" effects were identified. Using this elegant approach, Baudrie et al. (2) identified the frequency bands for sympathetic modulation of vascular tone at 0.15–0.60 Hz [almost identical to the results by Just et al. (9)] and for parasympathetic modulation of heart rate at 2.5–5.0 Hz. The results concerning sympathetic modulation of heart rate were inconclusive because mice were studied during resting conditions where sympathetic modulation of sinus node function may be less prominent.

With this regard, it is important to consider the experimental conditions under which hemodynamic recordings are obtained. For example, recovery from surgery, active vs. inactive states, or day vs. night are well known to affect cardiovascular parameters. It is reasonable to assume that the recordings in the study by Baudrie et al. (2) have been obtained after full recovery from surgical implantation of telemetry probes and during inactive conditions, because heart rate was only 400 beats/min. In addition, heart rate decreased only modestly after beta1-adrenergic receptor blockade but increased substantially after muscarinic receptor blockade, indicating that sympathetic tone was low and parasympathetic tone was high under these experimental conditions. To achieve true resting recordings in chronically instrumented mice, the use of telemetric sensors, as utilized in the study by Baudrie et al. (2), may be preferred over the use of exteriorized catheters. Furthermore, it has been demonstrated that a period of ~2 wk is required for full recovery and to reestablish circadian rhythms for blood pressure and heart rate after implantation of telemetric devices (12). Furthermore, active and inactive states may be separated and analyzed individually. This is particularly important in mice that tend to switch rapidly and spontaneously between active and inactive phases. The activity signal provided by some telemetry devices as well as temporal changes in the blood pressure and heart rate time series may provide some guidance in distinguishing active from inactive states (22).

Because high-frequency variability is defined as respiration-related variability, one may argue that the frequency range for high-frequency variability should be centered around the true respiration rate of each individual animal instead of using a fixed frequency range. However, this approach can prove problematic because determination of the respiration frequency is not always trivial. Under resting and inactive conditions, one typically finds a well-defined respiration peak in the blood pressure and heart rate spectra that can be used to identify the respiration rate. However, during active conditions, the respiration rate can be highly variable, and, thus, the respiration peak can be very difficult, if not impossible, to identify. In this case, a fixed frequency range for high-frequency variability is the only practical option. The data presented by Baudrie et al. (2) demonstrate that atropine affects spectral power of pulse interval "most significantly" in a frequency range from 2.5 to 5.0 Hz. Thus, this frequency range should be used for high-frequency variability in mice, if the experimental conditions do not allow identification of clear respiratory peaks in the power spectra.

It is also important to note, that the frequency ranges suggested by Baudrie et al. (2) were determined in C57BL6 mice obtained from Charles River, L’Arbresle, France. Since no other mouse strain was tested in this study, the question of strain differences remains open. However, the choice of C57BL6 mice is highly relevant, since this mouse strain is frequently used as a genetic background for genetically engineered mouse models (6, 8, 10, 15, 24, 25).

In conclusion, evidence suggests that sympathetic modulation of vascular tone in mice occurs at frequencies above 0.15 Hz (2, 9) and below 0.6 Hz (2) or 0.7 Hz (9). Furthermore, in mice, respiratory sinus arrhythmia affects heart rate variability most in a frequency band between 2.5 and 5.0 Hz. In the absence of clearly detectable respiration peaks in the power spectra, this fixed frequency range appears to be justified for quantification of high-frequency variability. Finally, predominance of sympathetic vs. parasympathetic modulation of cardiovascular function largely depends on experimental conditions. Telemetric recordings can be very useful to standardize these conditions.

FOOTNOTES


Address for correspondence: H. M. Stauss, The Univ. of Iowa, Dept. of Integrative Physiology, 410 Field House, Iowa City, IA 52242 (e-mail: harald-stauss{at}uiowa.edu)

REFERENCES

  1. Akselrod S, Gordon D, Ubel FA, Shannon DC, Berger AC, Cohen RJ. Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. Science 213: 220–222, 1981.[Abstract/Free Full Text]
  2. Baudrie V, Laude D, Elghozi J-L. Optimal frequency ranges for extracting information on cardiovascular autonomic control from the blood pressure and pulse interval spectrograms in mice. Am J Physiol Regul Integr Comp Physiol 291: R904–R912, 2007.
  3. Bertram D, Barres C, Cuisinaud G, Julien C. The arterial baroreceptor reflex of the rat exhibits positive feedback properties at the frequency of Mayer waves. J Physiol 513: 251–261, 1998.[Abstract/Free Full Text]
  4. Everson SA, Lynch JW, Kaplan GA, Lakka TA, Sivenius J, Salonen JT. Stress-induced blood pressure reactivity and incident stroke in middle-aged men. Stroke 32: 1263–1270, 2001.[Abstract/Free Full Text]
  5. Georgiadis D, Schwarz S, Cencetti S, Schwab S. Noninvasive monitoring of hypertensive breakthrough of cerebral autoregulation in a patient with acute ischemic stroke. Cerebrovasc Dis 14: 129–132, 2002.[CrossRef][ISI][Medline]
  6. Gross V, Tank J, Obst M, Plehm R, Blumer KJ, Diedrich A, Jordan J, Luft FC. Autonomic nervous system and blood pressure regulation in RGS2-deficient mice. Am J Physiol Regul Integr Comp Physiol 288: R1134–R1142, 2005.[Abstract/Free Full Text]
  7. Hall JE, Brands MW, Henegar JR. Angiotensin II and long-term arterial pressure regulation: the overriding dominance of the kidney. J Am Soc Nephrol 10, Suppl 12: S258–S265, 1999.
  8. Head GA, Obeyesekere VR, Jones ME, Simpson ER, Krozowski ZS. Aromatase-deficient (ArKO) mice have reduced blood pressure and baroreflex sensitivity. Endocrinology 145: 4286–4291, 2004.[Abstract/Free Full Text]
  9. Just A, Faulhaber J, Ehmke H. Autonomic cardiovascular control in conscious mice. Am J Physiol Regul Integr Comp Physiol 279: R2214–R2221, 2000.[Abstract/Free Full Text]
  10. Keller NR, Diedrich A, Appalsamy M, Miller LC, Caron MG, McDonald MP, Shelton RC, Blakely RD, Robertson D. Norepinephrine transporter-deficient mice respond to anxiety producing and fearful environments with bradycardia and hypotension. Neuroscience 139: 931–946, 2006.[CrossRef][ISI][Medline]
  11. Kirchheim HR. Systemic arterial baroreceptor reflexes. Physiol Rev 56: 100–176, 1976.[Free Full Text]
  12. Leon LR, Walker LD, DuBose DA, Stephenson LA. Biotelemetry transmitter implantation in rodents: impact on growth and circadian rhythms. Am J Physiol Regul Integr Comp Physiol 286: R967–R974, 2004.[Abstract/Free Full Text]
  13. Malliani A, Pagani M, Lombardi F, Cerutti S. Cardiovascular neural regulation explored in the frequency domain. Circulation 84: 482–492, 1991.
  14. Olufsen MS, Ottesen JT, Tran HT, Ellwein LM, Lipsitz LA, Novak V. Blood pressure and blood flow variation during postural change from sitting to standing: model development and validation. J Appl Physiol 99: 1523–1537, 2005.[Abstract/Free Full Text]
  15. Pelat M, Dessy C, Massion P, Desager JP, Feron O, Balligand JL. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E–/– mice in vivo. Circulation 107: 2480–2486, 2003.
  16. Persson PB. Modulations of cardiovascular control mechanisms and their interaction. Physiol Rev 76: 193–244, 1996.[Abstract/Free Full Text]
  17. Ponchon P, Elghozi JL. Contribution of the renin-angiotensin and kallikrein-kinin systems to short-term variability of blood pressure in two-kidney, one-clip hypertensive rats. Eur J Pharmacol 297: 61–70, 1996.[CrossRef][ISI][Medline]
  18. Rutan GH, Hermanson B, Bild DE, Kittner SJ, LaBaw F, Tell GS. Orthostatic hypotension in older adults. The Cardiovascular Health Study CHS Collaborative Research Group. Hypertension 19: 508–519, 1992.[Abstract/Free Full Text]
  19. Saul JP, Arai Y, Berger RD, Lilly LS, Colucci WS, Cohen RJ. Assessment of autonomic regulation in chronic congestive heart failure by heart rate spectral analysis. Am J Cardiol 61: 1292–1299, 1988.[CrossRef][ISI][Medline]
  20. Stauss HM, Gödecke A, Mrowka R, Schrader J, Persson PB. Enhanced blood pressure variability in eNOS-knock-out mice. Hypertension 33: 1359–1363, 1999.[Abstract/Free Full Text]
  21. Stauss HM, Kregel KC. Frequency response characteristic of sympathetic-mediated vasomotor waves in conscious rats. Am J Physiol Heart Circ Physiol 271: H1416–H1422, 1996.[Abstract/Free Full Text]
  22. Stauss HM, Lazartigues E, Habib A, Whiteis CA, Davisson RL, Abboud FM, Chapleau MW. Abnormalities in baroreflex and feed-forward control of heart rate in conscious hypertensive and hypercholesterolemic mice (Abstract). Hypertension 46: 816, 2005.
  23. Stauss HM, Persson PB. Role of nitric oxide in buffering short-term blood pressure fluctuations. News Physiol Sci 15: 229–233, 2000.[Abstract/Free Full Text]
  24. Witte K, Engelhardt S, Janssen BJ, Lohse M, Lemmer B. Circadian and short-term regulation of blood pressure and heart rate in transgenic mice with cardiac overexpression of the beta1-adrenoceptor. Chronobiol Int 21: 205–216, 2004.[CrossRef][ISI][Medline]
  25. Xue B, Skala K, Jones TA, Hay M. Diminished baroreflex control of heart rate responses in otoconia-deficient C57BL/6JEi head tilt mice. Am J Physiol Heart Circ Physiol 287: H741–H747, 2004.[Abstract/Free Full Text]



This article has been cited by other articles:


Home page
Cardiovasc ResHome page
F. Desjardins, I. Lobysheva, M. Pelat, B. Gallez, O. Feron, C. Dessy, and J.-L. Balligand
Control of blood pressure variability in caveolin-1-deficient mice: role of nitric oxide identified in vivo through spectral analysis
Cardiovasc Res, August 1, 2008; 79(3): 527 - 536.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. J. Swoap, C. Li, J. Wess, A. D. Parsons, T. D. Williams, and J. M. Overton
Vagal tone dominates autonomic control of mouse heart rate at thermoneutrality
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1581 - H1588.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Laude, V. Baudrie, and J.-L. Elghozi
Applicability of recent methods used to estimate spontaneous baroreflex sensitivity to resting mice
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R142 - R150.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. Farah, K. M. Elased, and M. Morris
Genetic and dietary interactions: role of angiotensin AT1a receptors in response to a high-fructose diet
Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1083 - H1089.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/2/R902    most recent
00716.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stauss, H. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stauss, H. M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2007 by the American Physiological Society.